OPT opthea limited
Add to My Watchlist 0.00% ! 60.0¢

interestingly COAST reports ph3 first in early Q2 2025 which is...

  1. primaus72
    3,951 Posts.
    lightbulb Created with Sketch. 188
    clock Created with Sketch.
    23/07/24
    23:21
    Post #: 74882933
    interestingly COAST reports ph3 first in early Q2 2025 which is trial with eyelea - eyelea has $6B+ in sales and from memory OPT p2b in comparison to eyelea was better result than against lucentis (which only does about $1.5B of sales p.a)

    So all in all - it’s the first trial result which will make or break this company
    OPT Price at posting: 38.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STN Excellent Gold Intercepts Demonstrate Robust Apollo Hill Resource
right-arrow Created with Sketch.
NEWS Trident Infill Drilling Results Confirm Resource as Development Gets Underway
right-arrow Created with Sketch.
NUZ Significant Blood-Brain Barrier Penetration Achieved by NUZ-001
right-arrow Created with Sketch.
NEWS Many are concerned about global falling birthrates. This diverse stock has solutions
right-arrow Created with Sketch.
NEWS INOVIQ Kills 88% of Lung and Breast Cancer Cells with New Lab Treatment
right-arrow Created with Sketch.
DAL Maiden work program to commence for Blue Lagoon Zirconium, Niobium and Rare Earth Project in Greenland
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
60.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $738.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.